Navigation Links
HYCOR Appoints Sean-Xavier Neath as Chief Medical Officer to Support Expansion of Product Lines and Enhance Customer Support Offerings
Date:7/19/2011

GARDEN GROVE, Calif., July 19, 2011 /PRNewswire/ -- HYCOR Biomedical, Inc., a leading manufacturer and marketer of in vitro diagnostic products, today announced that Sean-Xavier Neath, M.D., Ph.D., has been appointed as Chief Medical Officer (CMO). In this role, Dr. Neath will support the company as it works to expand its product lines and provide additional support for customers.

"We are pleased to welcome Dr. Neath to the HYCOR team and are confident he will have great impact on key areas of our business," said Dick Aderman, CEO, HYCOR. "Given his diverse background in the academic, clinical and business sectors we look forward to learning from his experience and leveraging his unique perspective during this important time of growth for the company."  

Dr. Neath brings extensive knowledge and leadership in the pharmaceutical and diagnostics industries having served in medical affairs positions for a number of leading companies, including BRAHMS USA and Biosite. During his time at BRAHMS USA, Dr. Neath lead new product development strategies, including clinical trial design and regulatory submission planning. In addition, Dr. Neath was responsible for medical education, marketing and reimbursement program development. In his role at Biosite, Dr. Neath provided strategic counsel to the business development, marketing, sales and R&D teams and also developed educational curricula for physician clients.

"I'm pleased to join the HYCOR team to identify product development opportunities and work to expand the customer support services that HYCOR customers value most," said Dr. Neath.

About HYCOR Biomedical, Inc.

Founded in 1981, HYCOR is a global manufacturer and marketer of in vitro diagnostics products. Since its founding, HYCOR has expanded its presence into urinalysis, allergy and autoimmune products used in clinical laboratories, hospitals and doctors' offices worldwide. Among its products, HYCOR markets t
'/>"/>

SOURCE HYCOR Biomedical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. HYCOR Expands Board of Directors to Support Growth in Key Areas
2. CoLucid Appoints Thomas P. Mathers as Chief Executive Officer
3. Regulus Therapeutics Appoints Gregory Hannon, Ph.D. to Scientific Advisory Board
4. GenturaDx Appoints Senior Vice President of Research & Development
5. H. D. Smith Appoints Mark de Bruin Corporate Vice President Managed Care
6. OncoSec Medical Appoints Engineering Leader
7. Tris Pharma Appoints Vice President of Human Resources
8. Cepheid Appoints Vice President of Infectious Disease Research & Development
9. InstantLabs Appoints Dr. Neil Sharma as Director of Product Development
10. Hotspur Technologies Appoints Fred Khosravi Chairman of the Board
11. Ampio Pharmaceuticals, Inc. Appoints New Independent Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014  Decision Resources Group finds that, for ... Brazil and Mexico ... prescribe long-acting beta-agonist (LABA)- and long-acting muscarinic antagonist ... current severe cost/coverage constraints. Therefore, new brands of ... launch in these countries—which will considerably expand the ...
(Date:8/21/2014)... Germany , Aug. 21, 2014  IBM (NYSE: ... Elektronen-Synchrotron ( DESY ), a leading national research center ... management and storage of massive volumes of x-ray data. ... based on IBM software defined technology can handle more ... performance and help scientists worldwide gain faster insights into ...
(Date:8/21/2014)...  Seventy-one percent of Americans believe the abuse of strong ... health and safety issue in the United States ... by Repass & Partners, a Cincinnati ... severity of the prescription medication abuse problem and the need ... health situation facing our country," Rex Repass , CEO ...
Breaking Medicine Technology:Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3
... Fla., Dec. 5, 2011 Hybrid Fuels, Inc., (Pink ... of its main business activities and new strategic goals.  ... a nutraceutical/pharmaceutical business venture that will focus on providing ... normally be treated or addressed with pharmaceutical drugs that ...
... Pharmaceuticals, Inc. (Nasdaq: ANTH ), a biopharmaceutical ... inflammation and autoimmune disorders, today announced Dr. Debra Odink ... Officer and Senior Vice President. "Over ... scientific leadership has been critical to the success of ...
Cached Medicine Technology:Hybrid Fuels, Inc. Announces New Business Strategy 2Anthera Pharmaceuticals Promotes Dr. Debra Odink to Chief Technology Officer 2
(Date:8/22/2014)... 22, 2014 Beat Eczema , ... can use natural methods to completely cure the eczema ... attention of Shane Michaels, prompting an investigative review. ... the skin, it can still be extremely debilitating and ... “The intense itching and pain that it causes on ...
(Date:8/22/2014)... time an oncogenic somatic mutation at amino acid 918 ... identified in small cell lung cancer (SCLC) tumors and ... produced increased intracellular signaling and cell growth. , SCLC ... 15% of all lung cancers and is strongly associated ... has been extensively examined for genomic alterations and targeted ...
(Date:8/22/2014)... Paying tuition and other related educational expenses ... for four nurse educators pursuing advanced degrees, thanks to ... Foundation for Nursing Education . This year’s recipients – ... than in 2013, thanks to these named NLN Foundation ... Marcil Endowment Funds, both donated by Kathy Mershon; the ...
(Date:8/22/2014)... August 22, 2014 Testosterone treatment ... in U.S. courts on behalf of men who ... use of prescription low testosterone therapies, Bernstein Liebhard ... claim was filed against Pfizer Inc. on July ... life-threatening heart issues due to his use of ...
(Date:8/22/2014)... Hudson County, NJ (PRWEB) August 22, 2014 ... that a leading specialist in Internal Medicine, Geriatrics, ... joined the network, CarePoint Health Medical Group. Their ... of highly skilled and experienced physicians comprise CarePoint ... doctors and practices in Hudson County, representing a ...
Breaking Medicine News(10 mins):Health News:Beat Eczema: Review Exposes Susan Clark’s Guide to Curing Eczema Naturally 2Health News:Novel oncogenic RET mutation found in small cell lung cancer 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Dr. Reisner Joins CarePoint Health Medical Group 2
... to Assure ... POWELL, Ohio, June 2 Click4Care, Inc., a ... payers,providers and patients, today announced that Cariten Healthcare, one ... subsidiary of,Covenant Health, has selected ThinkHealth for its medical ...
... Awarded Seven Gold Healthcare Advertising Marketing Awards, ... record number of over 4,400,entries, the 25th ... awards to Publicis Indianapolis and St. Vincent ... television), and marketing,work. Additionally, both entities won ...
... In a multi-site study, Oregon Health & Science University ... also known as MDX-010, works to stimulate the body,s own ... to be effective in study participants with a serious type ... and was resistant to hormonal treatment and, in some cases, ...
... (BioMedical Enterprises, Inc.),a privately held medical device company and ... launch of the OSSAnchor(TM),Grip, a nitinol implant designed to ... the first in the family of OSSAnchor(TM) nitinol soft,tissue ... Grip is a,nitinol implant with aggressive barbs on the ...
... Care Association Raising Profile of Key Issue Impacting,Texas Seniors, ... June 2 With just more than,five months until ... by Baselice Associates finds 57% of voters less likely ... she opposed increasing the amount,the state pays nursing homes ...
... Entitled, ,Ingenuity at Work, Discusses Abbott,s, Contributions to ... ABBOTT PARK, Ill., June 2 Abbott (NYSE: ... Report, "Ingenuity at Work,",which is available online at ... access to care, innovation, science,education and the environment., ...
Cached Medicine News:Health News:Click4Care Signs Award-Winning 500,000-Member Health Plan 2Health News:Publicis Indianapolis and St. Vincent Hospital Win the Gold 2Health News:OHSU Cancer Institute finds that drug stimulated immune system in prostate cancer 2Health News:OHSU Cancer Institute finds that drug stimulated immune system in prostate cancer 3Health News:BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSAnchor(TM) Grip Nitinol Soft Tissue Anchor 2Health News:Texas Eldercare Poll: 57 Percent Less Likely to Back Local Legislator if They Oppose Medicaid Rate Boost 2Health News:Texas Eldercare Poll: 57 Percent Less Likely to Back Local Legislator if They Oppose Medicaid Rate Boost 3Health News:Abbott Releases 2007 Global Citizenship Report Highlighting Strong Commitment to Access to Health Care 2Health News:Abbott Releases 2007 Global Citizenship Report Highlighting Strong Commitment to Access to Health Care 3
The rectangular large-field lens of the 2631 are ideal for reading and writing....
The Multi-Purpose Stand Magnifier is the most versatile stand magnifier. The stand has multiple configurations allowing for all situations where hands-free magnification is needed....
Thinprofile design eyelid implants....
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Medicine Products: